OS Therapies (OSTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    OS Therapies

    NYSE: OSTX · Real-Time Price · USD
    2.03
    -0.02 (-0.73%)
    At close: Sep 29, 2025, 3:59 PM
    2.02
    -0.49%
    After-hours: Sep 29, 2025, 07:58 PM EDT

    OS Therapies Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 2.78K 4.22K 805.00 805K
    Gross Profit
    		 -2.78K -4.22K -805 -805K
    Operating Income
    		 -6.81B -4.34M -4.45M -4.84M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -8.88B -7.79M -6.25M -7.42M
    Net Income
    		 -8.88M -7.79M -6.25M -7.42M
    Selling & General & Admin
    		 3.97M 1.12M 1.15M 1.5M
    Research & Development
    		 2.84M 3.22M 3.29M 2.17M
    Other Expenses
    		 -2.78K 5.15K 1.21K 1.16M
    Operating Expenses
    		 6.81M 4.34M 4.45M 4.84M
    Interest Expense
    		 2.05M 3.45M 1.81M 2.58M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -6.81M 4.34M 4.45M 4.84M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 20.87M 20.05M 23.1M 23.1M
    Shares Outstanding (Diluted)
    		 20.87M 20.05M 23.1M 23.1M
    EPS (Basic)
    		 -0.52 -0.39 -0.28 -0.33
    EPS (Diluted)
    		 -0.52 -0.39 -0.28 -0.33
    EBITDA
    		 -6.83M -4.34M -4.45M -4.84M
    EBIT
    		 -6.83M -4.34M -4.45M -4.84M
    Depreciation & Amortization
    		 2.78K 4.22K 805.00 805.00

    Add to Watchlist